Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03792984Phase 3Completed
Phase 3, randomised, double-blind trial (2 arms), sponsored by Damascus University. Primary endpoints: Quantitative Insulin Sensitivity Check Index at 8 weeks, Raynaud's index at 8 weeks and 1 more. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03792984.